Semaglutide vs. Tirzepatide: How the Two Big Drugs Compare
Modern Weight Science Editorial Team
Editorial Team
They're the two most-discussed GLP-1 medications, but they aren't the same drug. Here's a plain-language comparison of mechanism, results, and trade-offs.
Semaglutide and tirzepatide are the two medications most people are choosing between. They're related, but they are not the same drug — and the differences are worth understanding before you start.
The mechanism difference
Semaglutide is a GLP-1 receptor agonist — it mimics a single gut hormone (GLP-1) that influences appetite, satiety, and blood sugar. For a detailed breakdown of how it works at a molecular level, see How Semaglutide Works for Weight Loss.
Tirzepatide is a dual agonist: it acts on the GLP-1 receptor and the GIP receptor, a second gut hormone pathway. In trials, this dual action has generally produced larger average weight loss.
What the results look like
Across major clinical trials, tirzepatide has tended to produce greater average weight loss than semaglutide at its higher doses. The STEP 1 trial showed ~15% average weight loss for semaglutide 2.4mg; SURMOUNT-1 showed ~21% for tirzepatide 15mg. For full trial data, see GLP-1 Clinical Studies Explained and How Much Weight Can You Lose on Semaglutide.
But "average" hides a lot of individual variation — plenty of people do extremely well on semaglutide, and response depends on dose, consistency, diet, and biology. The right framing isn't "which is stronger" but "which is right for you, given access and tolerability."
Side effects
Both drugs share the same core side-effect profile — primarily gastrointestinal: nausea, constipation or diarrhea, and reduced appetite, most prominent during titration. Neither has a clear, decisive advantage in tolerability for the average person; it's quite individual. For a practical guide on injection technique and tolerability, see Semaglutide Injection Sites.
Practical factors that often decide it
- Cost and coverage. What your insurance covers — or what's available and affordable through a telehealth provider — often matters more than the trial averages.
- Availability. Supply of specific drugs and doses has fluctuated; the "best" drug you can't get consistently isn't the best choice.
- Your prescriber's judgment. Your medical history, other conditions, and goals all factor in.
The honest takeaway
Tirzepatide's dual mechanism gives it an edge in average trial weight loss. But both are highly effective medications, and the decision is usually settled by cost, access, and how your body responds — not by a leaderboard. This is a conversation to have with a prescriber, not a verdict to reach from an article. For more on how these medications compare to conventional approaches, see GLP-1 vs. Traditional Weight Loss.
This article is educational and not medical advice. Drug selection, dosing, and suitability are decisions for you and a licensed clinician.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Content reviewed against peer-reviewed research. Read our editorial policy →
Last updated May 2026
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but they are FDA-approved for different indications. Ozempic (up to 2mg) is approved for type 2 diabetes management and cardiovascular risk reduction. Wegovy (up to 2.4mg) is approved for chronic weight management. The distinction directly affects insurance coverage, maximum dose, and prescribing eligibility — and the two are not interchangeable through most pharmacies.
Do I need a prescription for semaglutide or tirzepatide?
Yes. Semaglutide and tirzepatide are prescription-only medications in the United States and most countries. They require evaluation and a prescription from a licensed healthcare provider. Compounded versions have been available through telehealth platforms, but these are not FDA-approved and carry different regulatory and quality considerations.
How long does it take to see results on GLP-1 medications?
Appetite changes are typically noticed in weeks 1-2. Meaningful weight loss (5-10% of body weight) generally occurs by weeks 12-20. Clinical trial results are measured at 68-72 weeks. The dose escalation schedule means the first 16-20 weeks are primarily about building tolerance, not maximum efficacy. Individual response varies significantly.
What happens when you stop taking a GLP-1 medication?
Most people regain a significant portion of lost weight within 12 months of stopping. Discontinuation studies show that the compensatory hunger and metabolic changes that GLP-1 medications suppress tend to return when the medication is withdrawn. Many clinicians now frame these as long-term treatments — similar to antihypertensives — rather than short-term interventions.
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.
Treatment Options
Clinically supervised approaches to metabolic health and weight management, evaluated by licensed physicians.
Ro Body
A physician-led telehealth program that evaluates your metabolic health and discusses FDA-cleared medication options where clinically appropriate.
Learn moreFound
Combines medical evaluation, pharmacotherapy when indicated, and behavioral coaching into a structured, ongoing metabolic health plan.
Learn moreCalibrate
A year-long metabolic reset built around GLP-1 medication, with physician oversight, registered dietitian support, and behavioral coaching.
Learn moreAffiliate disclosure: Modern Weight Science may earn a commission if you visit or purchase through these links, at no additional cost to you. Programs are listed for educational relevance. This is not a clinical recommendation — always consult a licensed healthcare professional before starting any treatment.
Weekly Digest
Get Evidence-Based Metabolic Health Insights Weekly
Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.
Continue reading
Related articles
Ozempic vs. Wegovy: Same Drug, Different Purposes
Ozempic and Wegovy both contain semaglutide, yet they are not interchangeable. The distinction between the two shapes everything from your insurance coverage to the maximum dose your prescriber can offer.
Wegovy Cost Without Insurance in 2025
The list price for Wegovy runs over $1,300 per month — but almost nobody pays that. Here is what Wegovy actually costs in 2025 across every realistic payment path.
Ozempic Savings Card: How to Pay $25/Month
Novo Nordisk's Ozempic savings card can reduce your monthly cost to $25 — but eligibility rules catch a lot of people off guard. Here is exactly how it works and who qualifies.
Best Telehealth for GLP-1 Prescriptions in 2025
The telehealth GLP-1 market is large, crowded, and uneven in quality. Here is a plain-language framework for evaluating providers — and the questions that actually separate good clinical care from a slick checkout page.